ASPIRIN GIVEN TWICE DAILY REDUCED THE PLATELET REACTIVITY MORE THAN ONCE DAILY IN PEOPLE WITH TYPE 2 DIABETES WITHOUT CARDIOVASCULAR DISEASE

ASPIRIN GIVEN TWICE DAILY REDUCED THE PLATELET REACTIVITY MORE THAN ONCE DAILY IN PEOPLE WITH TYPE 2 DIABETES WITHOUT CARDIOVASCULAR DISEASE

Bibliographic Details
Main Authors:	YiHong, S, Bethel, M, Holman, R, Sourij, H, Harrison, P, Tucker, L, Kennedy, I, White, S, Hill, L, Oulhaj, A, Coleman, R, Hu, D
Format:	Journal article
Published:	2013

Similar Items

Randomized controlled trial comparing impact on platelet reactivity of twice‐daily with once‐daily aspirin in people with type 2 diabetes
by: Bethel, M, et al.
Published: (2016)

Once- versus twice-daily aspirin treatment in patients with essential thrombocytosis
by: Mads Lamm Larsen, et al.
Published: (2019-04-01)

Fertility of dairy cows milked once daily or twice daily in New Zealand
by: J.M.D.R. Jayawardana, et al.
Published: (2022-11-01)

Twice-daily versus once-daily lisinopril and losartan for hypertension: Real-world effectiveness and safety.
by: Catherine G Derington, et al.
Published: (2020-01-01)

Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma
by: Woodcock Ashley, et al.
Published: (2011-12-01)

Twice-Daily versus Once-Daily Pramipexole Extended Release Dosage Regimens in Parkinson’s Disease
by: Ji Young Yun, et al.
Published: (2017-01-01)

A randomized trial of once daily versus twice daily dosing of oral iron in CKD
by: Vivek Sood, et al.
Published: (2023-01-01)

SIMPLE AND RATIONAL TWICE-DAILY INSULIN REGIME
by: Turner, R, et al.
Published: (1978)

Treatment of Hypertension: Favourable Effect of the Twice-Daily Compared to the Once-Daily (Evening) Administration of Perindopril and Losartan
by: Ipoly Szauder, et al.
Published: (2015-07-01)

Comparison of once-daily versus twice-daily dosing of valsartan in patients with chronic stable heart failure
by: Inder S Anand, et al.
Published: (2010-06-01)

Comparison of Once- with Twice-Daily Dosing of Fluticasone Propionate in Mild and Moderate Asthma
by: Louis-Philippe Boulet, et al.
Published: (2000-01-01)

Once-daily dose regimen of ribavirin is interchangeable with a twice-daily dose regimen: randomized open clinical trial
by: Balk JM, et al.
Published: (2015-08-01)

Comparison of health care resource utilization and costs among patients with GERD on once-daily or twice-daily proton pump inhibitor therapy
by: Mody R, et al.
Published: (2013-04-01)

Heritabilities and genetic and phenotypic correlations for milk production and fertility traits of spring-calved once-daily or twice-daily milking cows in New Zealand
by: J.M.D.R. Jayawardana, et al.
Published: (2023-03-01)

Effects of switching from twice-daily tacrolimus to once-daily extended-release meltdose tacrolimus on cellular immune response
by: Moritz Anft, et al.
Published: (2024-09-01)

Twice-daily versus once-daily antiretroviral therapy and coformulation strategies in HIV-infected adults: benefits, risks, or burden?
by: Nachega JB, et al.
Published: (2011-12-01)

Once- versus twice-daily abacavir and lamivudine in African children: the randomised controlled ARROW Trial
by: Musiime, V, et al.
Published: (2016)

Effects of Late Conversion from Twice-Daily to Once-Daily Slow Release Tacrolimus on the Insulin Resistance Indexes in Kidney Transplant Patients
by: Valeria Cademartori, et al.
Published: (2021-02-01)

A Meta-Analysis and Systematic Review of the Efficacy of Twice Daily PPIs versus Once Daily for Treatment of Gastroesophageal Reflux Disease
by: Hongying Zhang, et al.
Published: (2017-01-01)

Efficacy and safety of a switch from twice-daily tacrolimus to once-daily generic tacrolimus in stable liver transplant patients
by: Jong Man Kim, et al.
Published: (2021-09-01)

Once-daily versus twice-daily enoxaparin for the initial treatment of acute deep venous thrombosis: a case–control study
by: Mohamad T Yusuf, et al.
Published: (2019-01-01)

Characteristics of patients needing basal insulin to be given twice-daily or a second insulin formulation during the first year of the 4-T Trial
by: Levy, J, et al.
Published: (2008)

Twice- or once-daily dosing of direct oral anticoagulants and gastrointestinal bleeding in patient with atrial fibrillation
by: Tadakiyo Ido, et al.
Published: (2022-10-01)

A Phase I Randomized Trial of Once‐Daily Versus Twice‐Daily Recombinant Human Parathyroid Hormone (1‐84) for Hypoparathyroidism
by: Steven W. Ing, et al.
Published: (2023-07-01)

Retrospective Comparison of the Effectiveness and Safety of Ceftriaxone 1 g Twice Daily versus 2 g Once Daily for Treatment of Aspiration Pneumonia
by: Hideo Kato, et al.
Published: (2022-07-01)

Efficacy and safety of latanoprost/timolol fixed combination dosed twice daily compared to once daily in patients with primary open angle glaucoma
by: Anis Baidura Azal, et al.
Published: (2023-08-01)

Long-term retention on treatment with lumiracoxib 100 mg once or twice daily compared with celecoxib 200 mg once daily: A randomised controlled trial in patients with osteoarthritis
by: Notter Marianne, et al.
Published: (2008-03-01)

Once and Twice
by: Richard S. Kayne
Published: (2015-05-01)

Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers
by: Chiquette E, et al.
Published: (2012-11-01)

Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome
by: William A.E. Parker, et al.
Published: (2019-02-01)

Efficacy and safety of once daily oral administration of sodium‐glucose cotransporter‐2 inhibitor velagliflozin compared with twice daily insulin injection in diabetic cats
by: Stijn J. M. Niessen, et al.
Published: (2024-07-01)

Comparison of nine platelet function tests used to determine responses to different aspirin dosages in people with type 2 diabetes
by: Paul Harrison, et al.
Published: (2019-05-01)

Omeprazole Once or Twice Daily with Clarithromycin and Metronidazole for Helicobacter pylori Eradicaiton in a Canadian Community Practice
by: Naoki Chiba, et al.
Published: (2000-01-01)

Efficacy and toxicity of once versus twice daily regimens of amikacin in febrile neutropenic pediatric cancer patients
by: Reda Abd-Elfattah, et al.
Published: (2017-03-01)

An economic evaluation comparing once daily with twice daily mesalazine for maintaining remission based on results from a randomised controlled clinical trial.
by: Connolly, M, et al.
Published: (2009)

LONG-TERM EFFECTIVENESS, SAFETY, AND TOLERABILITY OF TWICE-DAILY DOSING WITH DEFERASIROX IN CHILDREN WITH TRANSFUSION-DEPENDENT THALASSEMIAS UNRESPONSIVE TO STANDARD ONCE-DAILY DOSING
by: Jassada Buaboonnam, et al.
Published: (2021-10-01)

Tacrolimus dose adjustment is not necessary in dose to dose conversion from a twice daily to a prolonged release once daily dose form
by: Kanitha Tiankanon, et al.
Published: (2022-06-01)

Efficacy of twice-daily vs once-daily sessions of repetitive transcranial magnetic stimulation in the treatment of major depressive disorder: a retrospective study
by: Modirrousta M, et al.
Published: (2018-01-01)

Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation
by: Doesch AO, et al.
Published: (2013-10-01)

Estimation of genetic parameters and individual and maternal breed, heterosis, and recombination loss effects for production and fertility traits of spring-calved cows milked once daily or twice daily in New Zealand
by: J.M.D.R. Jayawardana, et al.
Published: (2023-01-01)